| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |